Document:

QuickLinks
 -- Click here to rapidly navigate through this document
  

 
 

Exhibit 10.27    
    

  

	Dr. Todd Lorenz

c/o Corgentech Inc.	 	February 1, 2001

Dear
Todd: 

        It
is with great pleasure that I invite you to join the Corgentech team. We are building an exciting, new company dedicated to the discovery, development and commercialization of novel
therapies for cardiovascular diseases and other significant health conditions. As you know, our most advanced product is entering Phase III clinical development and is projected to be approved for
marketing in 2004. If successful, this product will alleviate a major cardiovascular health risk and thereby generate substantial revenues on a worldwide basis. We also have various research stage
projects that we anticipate will result in additional clinical candidates. 

        The
most important component of any successful company is its people. To accomplish successfully our goals, we are assembling a world-class team to support our research and development
efforts. Your
position at Corgentech would be Chief Medical Officer reporting to the President & CEO. We would request that commence your employment at Corgentech as soon as possible. 

        Your
duties at Corgentech would include: 

	•
	Management
of the clinical development efforts of the Company, including the design and execution of clinical trials; 
	•
	Management
of the Clinical Advisory Boards; 
	•
	Coordination
with Research in the identification and assessment of preclinical candidates; and 
	•
	Building
the Medical Affairs organization. 

        There
are four components to your compensation package for this position: 

	•
	First,
the base salary is $230,000 per year. 
	•
	Second,
subject to approval of the Board of Directors, a stock option grant to purchase 300,000 shares of Common Stock in Corgentech Inc. exercisable at $0.10 per
share. This stock option vests over four years with 25% of the grant vesting on your first anniversary date and the remainder of the option vesting in years two through four at a monthly rate of
1/48 of the total amount of the grant. You will also be eligible for additional stock grants as part of your annual review of compensation. 
	•
	Third,
the Company provides full benefits under its healthcare plans including health, life, vision and dental benefits. Our benefits administrator, StaffAdmin
Systems, Inc., will provide additional details on the benefits package. You will be entitled to three weeks vacation per year. At the end of five years of service, the Company provides all
employees with a six week paid sabbatical. The Company recognizes the importance of, and will support your attendance at, a reasonable number of professional conferences each year as well as
membership in professional organizations. 
	•
	Fourth,
if you are terminated for any reason other than Cause (defined below) during the first twelve (12) months of your employment, then you shall be entitled to
receive salary and health benefits for: (i) twelve (12) months after such date of termination, or (ii) until you obtain new employment, whichever is earlier. If you are terminated
for any reason other than Cause after the first twelve (12) months of your employment, then you shall be entitled to receive salary and 

1

 

health
benefits for: (i) six (6) months after such date of termination, or (ii) until you obtain new employment, whichever is earlier. Cause is defined as your acts or omissions
that constitute gross negligence, willful misconduct, fraud, criminal conduct, bad faith or malfeasance. 

        Before
the commencement of employment, we would request that you sign a confidentiality agreement and a proprietary inventions agreement. Copies of those agreements will be provided to
you separately. We hope that you will agree to join Corgentech as we build an organization dedicated to improving patient health by addressing unmet medical needs, and providing substantial value for
our shareholder and co-workers. Please indicate your acceptance by signing below. Welcome to Corgentech! 

Sincerely,

	/s/  JOHN P. MCLAUGHLIN      
 John P. McLaughlin

President & CEO	 	/s/  TODD LORENZ      
 Todd Lorenz

2

QuickLinks

Exhibit 10.27QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.28    
    

[Corgentech Letterhead]  

July 2,
2002 

Mr. James
Huang

c/o Corgentech Inc. 

Re:
Employment Terms 

Dear
James: 

        It
is with great pleasure that I invite you to join the Corgentech team. We are building an exciting, new company dedicated to the discovery, development and commercialization of novel
therapies for cardiovascular diseases and other significant health conditions. As you know, our most advanced product is in clinical development and is projected to be approved for marketing in 2005.
If successful, this product will alleviate a major cardiovascular health risk and thereby generate significant revenues. We also anticipate advancing one to two additional projects into the clinic
this year and have various research stage projects. 

        The
most important component of any successful company is its people. To accomplish successfully our goals, we are assembling a world-class team to support our research and development
efforts. Subject to final Board approval, Corgentech Inc. is pleased to offer you the position of Vice President of Business Development and Commercial Operations, on the following terms. You
will report to John P. McLaughlin, President and CEO. You will work at our facility located at 1651 Page Mill Road, Palo Alto, CA 94304. 

        Your
compensation will be $250,000 per year, less payroll deductions and all required withholdings. You will be eligible for a review in six months and will be credited with twelve
months of service at such review. You will be paid semi-monthly and you will be eligible for the following standard Company benefits: health, life, vision, and dental insurance, vacation,
sick leave, and holidays. Details about these benefits are available for your review from our benefits administrator, StaffAdmin Systems, Inc. Corgentech may modify compensation and benefits
from time to time as it deems necessary. You will receive a one time signing payment of $50,000. 

        The
Company will provide a loan to you in the amount of $200,000. The loan we be bear the lowest acceptable interest rate. Assuming continued service at Corgentech, the amount of loan is
forgivable over three years in equal annual increments of $66,666 plus accrued interest. If your employment terminates before the third year anniversary, the then outstanding balance shall be due. 

        We
will recommend to the Board of Directors of Corgentech (the "Board") that, at the next Board meeting on August 1, 2002, you be granted a stock option entitling you to purchase
up to 500,000 shares of Corgentech's common stock ("Common Stock") at the then current fair market value as determined by the Board at that meeting. Corgentech's standard vesting program provides that
twenty five percent (25%) of such options shall vest on the first anniversary of your date of employment, with the balance of your options vesting in equal monthly installments over the following
three years. The options will be subject to the terms and conditions of Corgentech's equity incentive plan and a stock option agreement, which will be sent to you separately. In addition, you will be
eligible for additional stock option grants. 

        As
a Corgentech officer, you will be expected to abide by Corgentech's rules and regulations, and sign a comply with the attached Proprietary Information and Inventions Agreement which
prohibits unauthorized use or disclosure of Corgentech proprietary information. Corgentech is an at-will employer. 

        The
employment terms in this letter supersede any other agreements or promises made to you by anyone, whether oral or written. As required by law, this offer is subject to satisfactory
proof of your right to work in the United States. 

        We
hope that you will agree to join Corgentech as we build an organization dedicated to improving patient health by addressing unmet medical needs and providing substantial value for our
stockholders and co-workers. Please sign and date this letter, and return it to me if you wish to accept employment at Corgentech under the terms described above. 

Welcome
to Corgentech! 

Sincerely,

	/s/  JOHN P. MCLAUGHLIN      
 John P. McLaughlin

President & CEO	 	 
	

Accepted:	
 	

 
	

/s/  JAMES HUANG      
 James Huang	
 	

7/18/02
 Date

        Attachment:
Proprietary Information and Inventions Agreement 

QuickLinks

Exhibit 10.28QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.29    
    

CORGENTECH INC.  

	TO:	 	James Huang
	

FROM:	
 	

John P. McLaughlin

President and CEO
	

RE:	
 	

Bonus Plan
	

DATE:	
 	

October 11, 2002

        Set
forth below is your bonus plan from Corgentech Inc. (the "Company") for the first three (3) years of your employment with the Company (the "Bonus Plan"). 

1.     Annual Bonus:  

        Provided that you are employed on the dates specified herein, you will receive a guaranteed bonus each year for three (3) years (each, a "Bonus Payment")
as follows: 

	Bonus Payment Date
 
	 	Amount

	October 11, 2003	 	$	75,666.66
	October 11, 2004	 	$	72,666.67
	October 11, 2005	 	$	69,666.67

        In
addition to this guaranteed bonus, the Company, at its discretion, may provide you with additional bonus opportunities. Each Bonus Payment is subject to standard payroll deductions
and withholdings. You must be employed by the Company at the time a Bonus Payment is payable in order to earn and receive the annual Bonus Payment. In the event your employment with the Company
terminates, for any reason, prior to the time each annual Bonus Payment is payable, you will receive a pro rata bonus calculated by multiplying your annual Bonus Payment amount by a fraction, the
numerator of which shall be the number of days in the applicable year beginning with the first day of such year and ending with your date of termination, and the denominator of which shall be three
hundred sixty-five (365). 

2.     At-Will Employment:  

        You understand that this Bonus Plan does not constitute a guarantee of continued employment with the Company and that your employment relationship with the
Company is at-will. As such, either you or the Company may terminate your employment at any time and for any reason, either with or without cause or advance notice. In addition, the
Company retains the right to modify your compensation and benefits, other than this Bonus Plan, within its sole discretion, upon notice to you. 

Agreed and Accepted:  

	/s/  JAMES HUANG      
 Print Name: James Huang	 	Date:	 	10/11/02

QuickLinks

Exhibit 10.29

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00059-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00059-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00059-of-00352.parquet"}]]